drugset / Trial / NCT06740474
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to assess safety, tolerability, and pharmacokinetics of single ascending doses (SAD) and multiple-ascending doses (MAD) of ABI-6250 in healthy participants. Effect of food will also be evaluated in Part A.
Timeline
- Start
- 2025-01-31
- Primary completion
- 2025-07-08
- Completion
- 2025-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABI-6250 | Unknown | — | — |